Ingerid W. Abrahamsen

Oslo, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Resetting Sensitivity to T Cell Redirection by Tumor Reduction and Immune Modulation.

Resetting Sensitivity to T Cell Redirection by Tumor Reduction and Immune Modulation.

Journal: Clinical lymphoma, myeloma & leukemia

Published: December 30, 2025

Hospital at Home Following Allogeneic Hematopoietic Stem Cell Transplantation: An Economic Analysis.

Hospital at Home Following Allogeneic Hematopoietic Stem Cell Transplantation: An Economic Analysis.

Journal: Healthcare (Basel, Switzerland)

Published: May 08, 2025

Should a young matched unrelated donor be preferred over an older matched related donor in allogeneic stem cell transplantation for acute leukemia and myelodysplastic syndrome?

Should a young matched unrelated donor be preferred over an older matched related donor in allogeneic stem cell transplantation for acute leukemia and myelodysplastic syndrome?

Journal: Bone marrow transplantation

Published: July 31, 2024

Ide-cel vs standard regimens in triple-class-exposed relapsed and refractory multiple myeloma: updated KarMMa-3 analyses.

Ide-cel vs standard regimens in triple-class-exposed relapsed and refractory multiple myeloma: updated KarMMa-3 analyses.

Journal: Blood

Published: April 29, 2024

Allogeneic stem cell transplant recipients surviving at least 2 years without relapse: outcome and risk factors.

Allogeneic stem cell transplant recipients surviving at least 2 years without relapse: outcome and risk factors.

Journal: EJHaem

Published: September 06, 2023

Allogeneic stem cell transplantation in adults 2015-21.

Allogeneic stem cell transplantation in adults 2015-21.

Journal: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke

Published: March 15, 2023

Chronic graft-versus-host disease

Chronic graft-versus-host disease

Journal: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke

Published: March 15, 2023

Case Report: Pure Red Cell Aplasia Caused by Refractory Parvovirus B19 Infection After Pancreas Transplantation Alone.

Case Report: Pure Red Cell Aplasia Caused by Refractory Parvovirus B19 Infection After Pancreas Transplantation Alone.

Journal: Frontiers in medicine

Published: January 06, 2022

Addition of Anti-thymocyte Globulin in Allogeneic Stem Cell Transplantation With Peripheral Stem Cells From Matched Unrelated Donors Improves Graft-Versus-Host Disease and Relapse Free Survival.

Addition of Anti-thymocyte Globulin in Allogeneic Stem Cell Transplantation With Peripheral Stem Cells From Matched Unrelated Donors Improves Graft-Versus-Host Disease and Relapse Free Survival.

Journal: Clinical lymphoma, myeloma & leukemia

Published: February 23, 2021

Superior Graft-versus-Host Disease-Free Relapse-Free Survival in Matched Unrelated Donor Hematopoietic Stem Cell Transplantation with Anti-Thymocyte Globulin (ATG) Compared to Matched Related Donor without ATG.

Superior Graft-versus-Host Disease-Free Relapse-Free Survival in Matched Unrelated Donor Hematopoietic Stem Cell Transplantation with Anti-Thymocyte Globulin (ATG) Compared to Matched Related Donor without ATG.

Journal: Transplantation and cellular therapy

Published: October 23, 2020

The CD34+ Cell Dose Matters in Hematopoietic Stem Cell Transplantation with Peripheral Blood Stem Cells from Sibling Donors.

The CD34+ Cell Dose Matters in Hematopoietic Stem Cell Transplantation with Peripheral Blood Stem Cells from Sibling Donors.

Journal: Clinical hematology international

Published: December 05, 2019

HLA-DPB1 mismatch reduce relapse and improve survival in T-cell replete unrelated donor allogeneic stem cell transplantation.

HLA-DPB1 mismatch reduce relapse and improve survival in T-cell replete unrelated donor allogeneic stem cell transplantation.

Journal: Bone marrow transplantation

Published: August 02, 2019

Showing 1-12 of 12

Last Updated: 09/26/2026